BDBM536502 (S)-5-(1-(2-((3-chloro- 6-(4-ethyl-2-methyl- piperazin-1-yl)-2- fluoropyridin-4-yl) amino)-2-oxoethyl)-4- oxo-4,6,7,8-tetrahydro- 1H-dipyrrolo[1,2-a:2',3'- d]pyrimidin-3-yl)-3- fluoro-2-hydroxy- benzamide::US11242351, Compound I-81

SMILES CCN1CCN([C@@H](C)C1)c1cc(NC(=O)Cn2cc(-c3cc(F)c(O)c(c3)C(N)=O)c3c2nc2CCCn2c3=O)c(Cl)c(F)n1

InChI Key InChIKey=MAPITTKSQDDVJU-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536502   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536502((S)-5-(1-(2-((3-chloro- 6-(4-ethyl-2-methyl- piper...)
Affinity DataKd:  1.55nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent